[ Price : $8.95]
FDAs Anti-Infective Drugs Advisory Committee votes down Theravances Vibativ (telavancin) for primary use in treating nosocomial pn...[ Price : $8.95]
The U.S. Court of Appeals for the District of Columbia Circuit denies a petition for rehearing from three former Purdue Frederick ...[ Price : $8.95]
A new CDRH report highlights significant improvements seen with its pre-market approval program since revamping it two years ago a...[ Price : $8.95]
Merck submits DTC research to showing that dual modality presentation of information in DTC ads increases recall and understanding...[ Price : $8.95]
Washington commentator Robert F. Steeves says the post-election political climate is conducive to removing all age limits on OTC e...[ Price : $8.95]
Public Citizen calls on FDA to immediately reinspect all compounding pharmacies that received Warning Letters in the past to ensur...[ Price : $8.95]
CBER issues a draft guidance with recommendations for information needed to support clinical trials for investigational cell, tiss...[ Price : $8.95]
FDAs Anti-Infective Drugs Advisory Committee unanimously votes to support efficacy findings with Janssen Research & Developments b...